Sector
PharmaceuticalsOpen
₹132.66Prev. Close
₹131.67Turnover(Lac.)
₹178.18Day's High
₹133Day's Low
₹12952 Week's High
₹31752 Week's Low
₹115Book Value
₹31.71Face Value
₹1Mkt Cap (₹ Cr.)
1,193.39P/E
49.87EPS
2.6Divi. Yield
015 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
14 May 2024
12:00 AM
BookCloser
14 May 2024
12:00 AM
AGM
Announcement Date: 14 May, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 9.2 | 9.2 | 9.2 | 9.19 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 292.07 | 272.62 | 234.28 | 176.61 |
Net Worth | 301.27 | 281.82 | 243.48 | 185.8 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 230.66 | 201.58 | 209.5 | 216.65 |
yoy growth (%) | 14.42 | -3.77 | -3.3 | 6.78 |
Raw materials | -78.2 | -63.18 | -71.66 | -70.7 |
As % of sales | 33.9 | 31.34 | 34.2 | 32.63 |
Employee costs | -39.98 | -44.27 | -44.61 | -39.99 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 32.24 | 18 | 9.39 | 16.39 |
Depreciation | -8.54 | -8.26 | -7.4 | -7.47 |
Tax paid | -5.62 | -2.09 | -0.1 | -1.6 |
Working capital | 7.89 | 27.14 | 18.07 | 18.93 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 14.42 | -3.77 | -3.3 | 6.78 |
Op profit growth | 39.8 | 39.17 | -21.85 | 4.4 |
EBIT growth | 45.57 | 45.24 | -24.69 | 5.8 |
Net profit growth | 67.29 | 71.19 | -37.16 | -1.8 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 405.51 | 381.76 | 354.32 | 394.61 | 230.67 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 405.51 | 381.76 | 354.32 | 394.61 | 230.67 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 10.59 | 23.56 | 25.12 | 17.88 | 13.1 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non-Exec & Non-Independent Dir
Rajneesh Anand
Independent Non Exe. Director
Hari Subramaniam
Managing Director & CEO
Sachin D Patel
Executive Chairman
Dinesh S Patel
Independent Non Exe. Director
Manjul Sandhu
Independent Non Exe. Director
Bhaskar Vemban Iyer
Independent Non Exe. Director
Shishir Dalal
Alternate Director
Reena S Patel
Non-Exec. & Independent Dir.
Nikunt Raval
Company Sec. & Compli. Officer
Pradeep Chandan.
Plot No 69 A GIDC Indl Estate,
Vapi,
Gujarat - 396195
Tel: 91-260-2421675
Website: http://www.themismedicare.com
Email: sangameshwar.iyer@themismedicare.com; cfoassist@th
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Themis Medicare Limited was formerly incorporated as Themis Chemicals Limited in 1969. The Company was originally promoted by Chemosyn and Medimpex but was taken over by a Group consisting of Shantibh...
Read More
Reports by Themis Medicare Ltd
What is the Themis Medicare Ltd share price today?
What is the Market Cap of Themis Medicare Ltd?
What is the PE and PB ratio of Themis Medicare Ltd?
What is the 52 Week High and Low of Themis Medicare Ltd?
What is the CAGR of Themis Medicare Ltd?
What is the shareholding pattern of Themis Medicare Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.